Functional bowel disorders in inflammatory bowel disease (Q34745766)

4 August 2017

1 reference

title

Functional bowel disorders in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

4 August 2017

main subject

0 references

inflammation

0 references

author name string

Michael A Pezzone

series ordinal

1

1 reference

4 August 2017

Arnold Wald

series ordinal

2

1 reference

4 August 2017

publication date

1 March 2002

1 reference

Gastroenterology Clinics of North America

4 August 2017

published in

1 reference

4 August 2017

volume

31

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

347-357

1 reference

Prevalence of proximal faecal stasis in active ulcerative colitis

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Review article: irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Role of loperamide and placebo in management of irritable bowel syndrome (IBS)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Imipramine in patients with chest pain despite normal coronary angiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Review article: an integrated approach to the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Basic and clinical aspects of visceral hyperalgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Psychometric scores and persistence of irritable bowel after infectious diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

The role of psychological and biological factors in postinfective gut dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Loperamide improves anal sphincter function and continence after restorative proctocolectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Symptoms of irritable bowel syndrome in ulcerative colitis in remission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Faecal stasis and diverticular disease in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Effect of psychotherapy on the course of Crohn's disease. Results of the German prospective multicenter psychotherapy treatment study on Crohn's disease. German Study Group on Psychosocial Intervention in Crohn's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Faecal stasis in proctocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Ulcerative colitis in remission: it is possible to predict the risk of relapse?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Irritable bowel syndrome--post salmonella infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Effect of wheat bran on weight of stool and gastrointestinal transit time: a meta analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Symptoms and stool patterns in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Functional Bowel Disease: Malabsorption and Abdominal Distress After Ingestion of Fructose, Sorbitol, and Fructose- Sorbitol Mixtures

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

A survey of acute and chronic disease associated with Yersinia enterocolitica infection. A Norwegian 10-year follow-up study on 458 hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Acute and chronic gastrointestinal manifestations associated with Yersinia enterocolitica infection. A Norwegian 10-year follow-up study on 458 hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Medical costs in community subjects with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

Loperamide oxide for the treatment of chronic diarrhoea in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2801%2900021-8

7 January 2021

10.1016/S0889-8553(01)00021-8

Identifiers

DOI

1 reference

4 August 2017

1 reference